| Literature DB >> 31073305 |
Qiaojing Qin1, Yingjun Qian1, Guanghua Zhu2, Weifeng Fan1, Jianying Niu1, Yong Gu1,3.
Abstract
OBJECTIVE: The elder diabetic patients increases rapidly in China and often accompany with hyperuricemia. Recently evidences show that renal function has been impaired in part of diabetic patients with normoalbuminuria. Therefore, we investigated the relationship between serum uric acid (SUA) and renal function in Chinese elder diabetes with normoalbuminuria.Entities:
Year: 2019 PMID: 31073305 PMCID: PMC6470449 DOI: 10.1155/2019/1435875
Source DB: PubMed Journal: Int J Endocrinol ISSN: 1687-8337 Impact factor: 3.257
General clinical characteristics of hyperuricemia in patients.
| Parameter | N (%) | Age (years) |
|---|---|---|
| Total | 1052 | 75.59 ± 4.32 |
| hyperuricemia | 222 (21.10%) | 76.35 ± 4.27 |
| male | 478 (45.44%) | 75.56 ± 4.44 |
| hyperuricemia | 79 (16.53%) | 75.87 ± 4.51 |
| Female | 574 (54.56%) | 75.61 ± 4.23 |
| hyperuricemia | 143 (24.91%) | 76.65 ± 4.10 |
Clinical data in male patients according to SUA quartile.
| Parameter | Q1 group | Q2 group | Q3 group | Q4 group | P value |
|---|---|---|---|---|---|
| (SUA≤295) | (347≥SUA≥296) | (406≥SUA≥348) | (SUA≥407) | ||
| n | 124 | 116 | 119 | 119 | |
| Age (years) | 75.08 ± 4.67 | 75.5 ± 4.53 | 75.44 ± 3.90 | 75.92 ± 4.61 | 0.917 |
| SBP (mmHg) | 134.13 ± 15.94 | 133.43 ± 13.56 | 137.22 ± 20.82 | 135.22 ± 14.36 | 0.309 |
| DBP (mmHg) | 79.52 ± 8.84 | 79.81 ± 8.37 | 80.21 ± 8.11 | 80.16 ± 7.44 | 0.378 |
| WC (cm) | 85.25 ± 8.03 | 86.06 ± 8.46 | 87.73 ± 8.27 | 87.97 ± 9.41 | 0.037 |
| WHR | 0.89 ± 0.05 | 0.91 ± 0.05 | 0.92 ± 0.06 | 0.92 ± 0.07 | 0.003 |
| BMI (kg/m2) | 24.24 ± 3.07 | 24.34 ± 2.81 | 25.08 ± 3.12 | 25.35 ± 3.10 | 0.009 |
| FBG (mmol/L) | 8.79 ± 3.10 | 7.79 ± 2.78 | 7.50 ± 1.73 | 7.43 ± 1.59 | <0.001 |
| HbA1c(%) | 7.69 ± 2.24 | 7.36 ± 1.89 | 6.99 ± 1.33 | 6.92 ± 1.17 | <0.001 |
| TC (mmol/L) | 4.67 ± 0.86 | 4.66 ± 0.95 | 4.58 ± 1.05 | 4.79 ± 0.89 | 0.382 |
| TG (mmol/L) | 1.27 ± 0.62 | 1.53 ± 1.07 | 1.50 ± 0.65 | 1.97 ± 1.08 | <0.001 |
| LDL-C (mmol/L) | 2.78 ± 0.63 | 2.76 ± 0.65 | 2.68 ± 0.82 | 2.83 ± 0.65 | 0.426 |
| HDL-C (mmol/L) | 1.27 ± 0.27 | 1.21 ± 0.25 | 1.19 ± 0.29 | 1.13 ± 0.19 | <0.001 |
| eGFR (ml/min/1.73m2) | 89.95 ± 8.01 | 88.80 ± 9.32 | 82.51 ± 10.47 | 78.70 ± 12.72 | <0.001 |
| leukocyte (x109/L) | 6.17 ± 1.57 | 6.04 ± 1.40 | 6.47 ± 1.55 | 6.39 ± 1.57 | 0.105 |
| Hb(g/L) | 143.31 ± 13.12 | 145.11 ± 15.22 | 144.40 ± 12.61 | 145.24 ± 13.24 | 0.674 |
| SUA( | 258.71 ± 27.45 | 322.25 ± 15.66 | 376.76 ± 17.83 | 456.53 ± 57.28 | <0.001 |
| Urine pH | 5.98 ± 0.85 | 5.73 ± 0.67 | 5.68 ± 0.76 | 5.61 ± 0.69 | 0.001 |
| UACR | 10.73 ± 7.03 | 9.06 ± 6.69 | 9.08 ± 6.71 | 10.37 ± 8.13 | 0.154 |
Compared with Q1 group, ∗P<0.05; compared with Q2 group, ∆P<0.05; compared with Q3 group, #P<0.05; systolic blood pressure (SBP), diastolic blood pressure (DBP), waist circumference (WC), waist-to-hip ratio (WHR), body mass index (BMI), fasting blood glucose (FBG), glycated hemoglobin (HbA1c), triglyceride (TG), total cholesterol (TC), low density lipoprotein-cholesterol (LDL-C), high density lipoprotein-cholesterol (HDL-C), hemoglobin (Hb), serum uric acid (SUA), and urinary albumin creatinine ratio (UACR).
Clinical data in female patients according to SUA quartile.
| Parameter | Q1 group | Q2 group | Q3 group | Q4 group | P value |
|---|---|---|---|---|---|
| (SUA≤266) | (309≥SUA≥267) | 359≥SUA≥310 | (≥360) | ||
| n | 150 | 139 | 142 | 143 | |
| Age (years) | 75.35 ± 4.40 | 75.03 ± 3.90 | 75.41 ± 4.34 | 76.65 ± 4.11 | 0.007 |
| SBP (mmHg) | 133.69 ± 14.39 | 135.99 ± 15.38 | 136.37 ± 16.74 | 138.50 ± 14.91 | 0.066 |
| DBP (mmHg) | 78.31 ± 7.46 | 78.50 ± 7.90 | 80.01 ± 7.82 | 80.78 ± 7.39 | 0.015 |
| WC (cm) | 82.11 ± 8.55 | 82.44 ± 8.52 | 83.09 ± 8.37 | 85.36 ± 8.46 | 0.005 |
| WHR | 0.88 ± 0.06 | 0.88 ± 0.06 | 0.88 ± 0.07 | 0.89 ± 0.06 | 0.557 |
| BMI (kg/m2) | 24.15 ± 3.47 | 24.73 ± 3.34 | 24.78 ± 3.20 | 25.83 ± 3.31 | <0.001 |
| FBG (mmol/L) | 8.39 ± 2.84 | 7.48 ± 1.91 | 7.62 ± 2.08 | 7.65 ± 1.94 | 0.002 |
| HbA1c(%) | 7.56 ± 1.99 | 6.93 ± 1.39 | 6.88 ± 1.29 | 7.00 ± 1.35 | <0.001 |
| TC (mmol/L) | 5.23 ± 1.00 | 5.04 ± 1.03 | 5.20 ± 0.92 | 5.41 ± 1.06∆ | 0.021 |
| TG (mmol/L) | 1.56 ± 0.70 | 1.70 ± 1.39 | 1.85 ± 1.07 | 2.17 ± 1.49 | <0.001 |
| LDL-C (mmol/L) | 2.99 ± 0.67 | 2.89 ± 0.74 | 3.02 ± 0.61 | 3.09 ± 0.79 | 0.132 |
| HDL-C (mmol/L) | 1.37 ± 0.30 | 1.34 ± 0.28 | 1.26 ± 0.25 | 1.25 ± 0.25 | <0.001 |
| eGFR (ml/min/1.73m2) | 90.01 ± 8.10 | 88.75 ± 6.49 | 85.63 ± 11.41 | 78.75 ± 14.42 | <0.001 |
| Leukocyte (x109/L) | 6.03 ± 1.49 | 5.94 ± 1.36 | 6.34 ± 1.48 | 7.02 ± 1.86 | <0.001 |
| Hb(g/L) | 135.13 ± 11.41 | 134.41 ± 14.78 | 132.49 ± 10.23 | 133.08 ± 16.72 | 0.325 |
| SUA( | 230.68 ± 25.69 | 288.58 ± 12.80 | 331.44 ± 14.67 | 416.80 ± 55.95 | <0.001 |
| Urine pH | 5.81 ± 0.75 | 5.67 ± 0.70 | 5.67 ± 0.72 | 5.58 ± 0.72 | 0.057 |
| UACR | 11.77 ± 7.27 | 11.23 ± 7.34 | 11.10 ± 7.57 | 12.31 ± 7.72 | 0.508 |
Compared with Q1 group, ∗P<0.05; compared with Q2 group, ∆P<0.05; compared with Q3 group, #P<0.05;
Linear correlation between eGFR and parameters including SUA.
| Variables | Total | Male | Female | |||
|---|---|---|---|---|---|---|
| (n=1052) | (n=478) | (n=574) | ||||
| r value | P value | r value | P value | r value | P value | |
| Age | -0.407 | <0.001 | -0.355 | <0.001 | -0.454 | <0.001 |
| SBP | 0.039 | 0.207 | -0.028 | 0.545 | -0.054 | 0.196 |
| DBP | 0.003 | 0.919 | -0.019 | 0.685 | -0.013 | 0.765 |
| WC | -0.066 | 0.031 | -0.042 | 0.360 | -0.060 | 0.151 |
| WHR | -0.064 | 0.038 | -0.042 | 0.361 | -0.055 | 0.189 |
| BMI | -0.045 | 0.142 | -0.047 | 0.307 | -0.047 | 0.262 |
| FBG | 0.115 | <0.001 | 0.180 | <0.001 | 0.065 | 0.122 |
| HbA1c | 0.105 | <0.001 | 0.146 | 0.001 | 0.073 | 0.082 |
| TC | 0.031 | 0.319 | -0.012 | 0.790 | 0.027 | 0.518 |
| TG | -0.027 | 0.381 | -0.085 | 0.062 | -0.008 | 0.857 |
| LDL-C | 0.004 | 0.887 | -0.028 | 0.544 | 0.006 | 0.881 |
| HDL-C | 0.092 | 0.003 | 0.097 | 0.034 | 0.064 | 0.125 |
| Leukocyte | -0.154 | <0.001 | -0.112 | 0.014 | -0.189 | <0.001 |
| Hb | 0.081 | 0.008 | 0.040 | 0.382 | 0.182 | <0.001 |
| SUA | -0.415 | <0.001 | -0.396 | <0.001 | -0.422 | <0.001 |
| Urine PH | 0.098 | 0.002 | 0.130 | 0.004 | -0.079 | 0.060 |
| UACR | -0.034 | 0.272 | -0.005 | 0.905 | -0.073 | 0.079 |
Multiple linear stepwise regression analysis for association between eGFR and SUA in all patients.
| variables | B | SE | Beta | t | P value |
|---|---|---|---|---|---|
| (constant) | 167.924 | 6.117 | 27.453 | P<0.001 | |
| SUA | -0.052 | 0.004 | -0.367 | -13.977 | P<0.001 |
| Age | -0.946 | 0.067 | -0.363 | -14.103 | P<0.001 |
| Leukocyte | -0.612 | 0.186 | -0.086 | -3.296 | 0.001 |
| Hb | 0.054 | 0.020 | 0.069 | 2.680 | 0.007 |
| FBG | 0.270 | 0.127 | 0.055 | 2.119 | 0.034 |
Serum uric acid (SUA), hemoglobin (Hb), and fasting blood glucose (FBG).
Multiple linear stepwise regression analysis for association between eGFR and SUA in male patients.
| variables | B | SE | Beta | t | P value |
|---|---|---|---|---|---|
| (constant) | 163.498 | 7.917 | 20.650 | P<0.001 | |
| SUA | -0.048 | 0.006 | -0.348 | -8.652 | P<0.001 |
| Age | -0.823 | 0.097 | -0.331 | -8.477 | P<0.001 |
| FBG | 0.432 | 0.190 | 0.091 | 2.273 | 0.023 |
| Leukocyte | -0.623 | 0.283 | -0.086 | -2.206 | 0.028 |
Multiple linear stepwise regression analysis for association between eGFR and SUA in female patients.
| variables | B | SE | Beta | t | P value |
|---|---|---|---|---|---|
| (constant) | 171.976 | 8.218 | 20.926 | P<0.001 | |
| Age | -1.063 | 0.091 | -0.394 | -11.642 | P<0.001 |
| SUA | -0.052 | 0.005 | -0.347 | -9.947 | P<0.001 |
| Hb | 0.107 | 0.029 | 0.127 | 3.753 | P<0.001 |
| Leukocyte | -0.574 | 0.247 | -0.081 | -2.323 | 0.021 |